Treatment of a damaged brachial plexus with help of stromal vascular fraction cell from adipose tissue
The aim of the study – to accelerate the repair of the damaged brachial plexus using cells of the stromal vascular fraction isolated from adipose tissue. Materials and methods. The study was carried out in 62 patients using stromal-vascular fraction cells from adipose tissue and classical methods of...
Gespeichert in:
Veröffentlicht in: | Vestnik medit͡s︡inskogo instituta Reaviz 2023-03, Vol.13 (1), p.56-63 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng ; rus |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The aim of the study
– to accelerate the repair of the damaged brachial plexus using cells of the stromal vascular fraction isolated from adipose tissue.
Materials and methods.
The study was carried out in 62 patients using stromal-vascular fraction cells from adipose tissue and classical methods of treatment for brachial plexus injury. The effectiveness of regeneration was evaluated using electromyographic examination and positive recovery of motor and sensory function.
Results and discussion.
Assessment of the results of surgical treatment with stromal vascular fraction cells from adipose tissue after brachial plexus neurolysis revealed the restoration of early M3-M5 and S3-S4 functions in 90 % of patients, and in the comparison group – 68 % respectively. The number of patients with M4-M5 functions in the group using the stromal vascular fraction for brachial plexus neurotization was 85 %, while in the control group it was 64 %, respectively. Electroneuromyography data also indicated an increase in the average number of motor units by 30 % after using cells of the stromal-vascular fraction from adipose tissue, in contrast to the comparison group.
Conclusion.
Stromal vascular cells isolated from adipose tissue appear to be promising stimulants of brachial plexus injury repair. |
---|---|
ISSN: | 2226-762X 2782-1579 |
DOI: | 10.20340/vmi-rvz.2023.1.CLIN.3 |